Blogs

Explore the latest thought leadership from Credence MedSystems on injectable drug delivery challenges, evolving therapy requirements, device and user considerations, and pharmaceutical manufacturing.

3 mL and 5 mL Prefilled Syringes: How Integrated Needle Safety Improves Usability, Sustainability, and Total Cost of Ownership

August 31, 2026 / Comments Off on 3 mL and 5 mL Prefilled Syringes: How Integrated Needle Safety Improves Usability, Sustainability, and Total Cost of Ownership

Pharmaceutical pipelines are creating growing demand for larger-volume injectable drug delivery. By accommodating greater delivery volumes, 3 mL and 5 mL prefilled syringes can provide greater flexibility in formulation and dose delivery and may reduce the need for higher drug concentrations or multiple injections. Moving to a larger-volume prefilled syringe has implications beyond drug capacity. […]

Intravitreal Injections: How Dose-Assist Devices Support Safer, More Accurate Drug Delivery

August 25, 2026 / 0 Comments

Intravitreal biologics and other therapies have transformed the treatment of retinal disease, but they have also concentrated significant clinical stakes into a single, sub-100-microliter injection. Unlike a subcutaneous or intramuscular dose, an intravitreal injection is delivered directly into a small, delicate, and largely incompressible compartment of the eye, where even small variability in delivered volume, […]